表紙:口周囲皮膚炎治療の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2023年から2030年予測
市場調査レポート
商品コード
1314719

口周囲皮膚炎治療の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2023年から2030年予測

Global Perioral Dermatitis Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日: | 発行: Value Market Research | ページ情報: 英文 177 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
口周囲皮膚炎治療の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2023年から2030年予測
出版日: 2023年07月01日
発行: Value Market Research
ページ情報: 英文 177 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

口周囲皮膚炎治療市場の世界需要は、2022年の6,900万米ドルから2030年にはほぼ1億2,115万米ドルの市場規模に達すると推定され、調査期間2023年~2030年のCAGRは7.29%です。

口周囲皮膚炎は、口や鼻、時には目の周囲に小さな赤いぶつぶつや丘疹ができることを特徴とする皮膚疾患です。かゆみ、ほてり、軽い不快感を引き起こすことがあります。口周囲皮膚炎の治療には、一般的にセルフケアと医療介入の組み合わせが用いられます。

市場力学:

口腔周囲皮膚炎の有病率の増加とこの疾患に対する意識の高まりが、効果的な治療に対する需要を牽引しています。不快感や自意識を引き起こし、QOL(生活の質)に影響を与えることが、治療法を求める動機となっています。現在進行中の研究が症状の理解と新たな治療アプローチの開発に焦点を当てているため、医学研究の開拓が市場を牽引する上で重要な役割を果たしています。皮膚科医やヘルスケア専門家による推奨は、症状の診断、治療法の処方、継続的なケアの提供につながるため、市場に影響を与えます。患者の嗜好や経験も市場を形成し、良好な結果や口コミによる推奨が治療を求める個人の選択に影響を与えます。治療オプションの有効性と安全性は重要な推進力であり、副作用を最小限に抑えながら症状を軽減し、皮膚の外観を改善する有効性が実証された治療法を、患者は求めています。皮膚科治療に関する規制の枠組みやガイドラインは市場に影響を与え、特定の治療オプションの入手可能性や利用しやすさに影響を与えます。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、口周囲皮膚炎治療の世界市場における各セグメントを包括的に評価することもできます。口周囲皮膚炎治療産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析:

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける口周囲皮膚炎治療市場の現在と将来の需要を強調する地域展望をカバーします。さらに、このレポートでは、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 口周囲皮膚炎治療- 産業分析

  • イントロダクション:市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 口周囲皮膚炎治療の世界市場分析:診断別

  • 診断別概要
  • 実績データと予測データ
  • 診断別分析
  • 皮膚生検
  • 健康診断
  • その他

第6章 口周囲皮膚炎治療の世界市場分析:治療別

  • 治療別概要
  • 実績データと予測データ
  • 治療別の分析
  • 抗生物質
  • イベルメクチン外用剤
  • 免疫抑制剤
  • その他

第7章 口周囲皮膚炎治療の世界市場分析:エンドユーザー別

  • エンドユーザー別概要
  • 実績データと予測データ
  • エンドユーザー別分析
  • 在宅医療
  • 専門クリニック
  • 病院
  • その他

第8章 口周囲皮膚炎治療の世界市場分析:地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績および予測
    • 北米:セグメント別
    • 北米:国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績および予測
    • 欧州:セグメント別
    • 欧州:国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績および予測
    • アジア太平洋地域:セグメント別
    • アジア太平洋地域:国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績および予測
    • ラテンアメリカ:セグメント別
    • ラテンアメリカ:国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績および予測
    • 中東・アフリカ:セグメント別
    • 中東・アフリカ:国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第9章 口周囲皮膚炎治療薬企業の競合情勢

  • 口周囲皮膚炎治療市場の競合
  • 提携/協力/合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第10章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Pfizer Inc.
  • Novartis International AG
  • Johnson & Johnson
  • Roche Holding AG
  • Merck & Co. Inc.
  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Sanofi SA
  • AbbVie Inc.
  • Gilead Sciences Inc.
  • Bristol Myers Squibb Company
  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.

注-企業プロファイルにおいて、財務の詳細や最近の動向は、入手可能な情報に基づいているか、非公開会社の場合はカバーしていない可能性があります。

図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Diagnosis (USD MN)
  • Skin Biopsy Market Sales by Geography (USD MN)
  • Physical Examination Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Treatment (USD MN)
  • Antibiotics Market Sales by Geography (USD MN)
  • Topical Ivermectin Market Sales by Geography (USD MN)
  • Immunosuppressive Agents Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End-User (USD MN)
  • Homecare Market Sales by Geography (USD MN)
  • Specialty Clinics Market Sales by Geography (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Perioral Dermatitis Treatment Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Perioral Dermatitis Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Perioral Dermatitis Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Diagnosis
  • Market Attractiveness Analysis by Treatment
  • Market Attractiveness Analysis by End-User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Diagnosis (USD MN)
  • Skin Biopsy Market Sales by Geography (USD MN)
  • Physical Examination Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Treatment (USD MN)
  • Antibiotics Market Sales by Geography (USD MN)
  • Topical Ivermectin Market Sales by Geography (USD MN)
  • Immunosuppressive Agents Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-User (USD MN)
  • Homecare Market Sales by Geography (USD MN)
  • Specialty Clinics Market Sales by Geography (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112111641

The global demand for Perioral Dermatitis Treatment Market is presumed to reach the market size of nearly USD 121.15 MN by 2030 from USD 69 MN in 2022 with a CAGR of 7.29% under the study period 2023 - 2030.

Perioral dermatitis is a skin condition which is characterized by the presence of small, red bumps or papules around the mouth, nose, and sometimes the eyes. It can cause itching, burning, and mild discomfort. The treatment of perioral dermatitis typically involves a combination of self-care measures and medical interventions.

MARKET DYNAMICS:

The increasing prevalence of perioral dermatitis and greater awareness of the condition drive the demand for effective treatments. Its impact on quality of life, causing discomfort and self-consciousness, motivates individuals to seek treatment options. Advancements in medical research play a crucial role in driving the market as ongoing studies focus on understanding the condition and developing new treatment approaches. Recommendations from dermatologists and healthcare professionals influence the market as they diagnose the condition, prescribe treatments, and provide ongoing care. Patient preferences and experiences also shape the market, as positive outcomes and word-of-mouth recommendations influence the choices of individuals seeking treatment. The efficacy and safety of treatment options are key drivers, with individuals seeking treatments that have demonstrated effectiveness in reducing symptoms and improving skin appearance while minimizing side effects. Regulatory frameworks and guidelines for dermatological treatments impact the market, affecting the availability and accessibility of specific treatment options.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of perioral dermatitis treatment. The growth and trends of perioral dermatitis treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the perioral dermatitis treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Diagnosis

  • Skin Biopsy
  • Physical Examination
  • Others

By Treatment

  • Antibiotics
  • Topical Ivermectin
  • Immunosuppressive Agents
  • Others

By End-User

  • Homecare
  • Specialty Clinics
  • Hospitals
  • Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Perioral Dermatitis Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Perioral Dermatitis Treatment market include Pfizer Inc., Novartis International AG, Johnson & Johnson, Roche Holding AG, Merck & Co., Inc., GlaxoSmithKline plc, AstraZeneca plc, Sanofi SA, AbbVie Inc., Gilead Sciences, Inc., Bristol Myers Squibb Company, Eli Lilly and Company, Novo Nordisk A/S, Amgen Inc., Teva Pharmaceutical Industries Ltd., Bayer AG, Takeda Pharmaceutical Company Limited, Moderna, Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals, Inc., Biogen Inc., Celgene Corporation, Astellas Pharma Inc., and Alexion Pharmaceuticals, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . PERIORAL DERMATITIS TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Diagnosis
    • 3.7.2 Market Attractiveness Analysis By Treatment
    • 3.7.3 Market Attractiveness Analysis By End-User
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PERIORAL DERMATITIS TREATMENT MARKET ANALYSIS BY DIAGNOSIS

  • 5.1 Overview by Diagnosis
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Diagnosis
  • 5.4 Skin Biopsy Historic and Forecast Sales by Regions
  • 5.5 Physical Examination Historic and Forecast Sales by Regions
  • 5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL PERIORAL DERMATITIS TREATMENT MARKET ANALYSIS BY TREATMENT

  • 6.1 Overview by Treatment
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Treatment
  • 6.4 Antibiotics Historic and Forecast Sales by Regions
  • 6.5 Topical Ivermectin Historic and Forecast Sales by Regions
  • 6.6 Immunosuppressive Agents Historic and Forecast Sales by Regions
  • 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL PERIORAL DERMATITIS TREATMENT MARKET ANALYSIS BY END-USER

  • 7.1 Overview by End-User
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-User
  • 7.4 Homecare Historic and Forecast Sales by Regions
  • 7.5 Specialty Clinics Historic and Forecast Sales by Regions
  • 7.6 Hospitals Historic and Forecast Sales by Regions
  • 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL PERIORAL DERMATITIS TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE PERIORAL DERMATITIS TREATMENT COMPANIES

  • 9.1. Perioral Dermatitis Treatment Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF PERIORAL DERMATITIS TREATMENT INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Pfizer Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Novartis International AG
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Johnson & Johnson
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Roche Holding AG
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Merck & Co. Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. GlaxoSmithKline plc
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. AstraZeneca plc
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Sanofi SA
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. AbbVie Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Gilead Sciences Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments
  • 10.13. Bristol Myers Squibb Company
    • 10.13.1. Company Overview
    • 10.13.2. Company Revenue
    • 10.13.3. Products
    • 10.13.4. Recent Developments
  • 10.14. Eli Lilly and Company
    • 10.14.1. Company Overview
    • 10.14.2. Company Revenue
    • 10.14.3. Products
    • 10.14.4. Recent Developments
  • 10.15. Novo Nordisk A/S
    • 10.15.1. Company Overview
    • 10.15.2. Company Revenue
    • 10.15.3. Products
    • 10.15.4. Recent Developments
  • 10.16. Amgen Inc.
    • 10.16.1. Company Overview
    • 10.16.2. Company Revenue
    • 10.16.3. Products
    • 10.16.4. Recent Developments
  • 10.17. Teva Pharmaceutical Industries Ltd.
    • 10.17.1. Company Overview
    • 10.17.2. Company Revenue
    • 10.17.3. Products
    • 10.17.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies